Vaccines, blood, antisera, toxins and cultures in   Latvia

Exports In 2022, Latvia exported $52.3M in Vaccines, blood, antisera, toxins and cultures, making it the 47th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 77th most exported product in Latvia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Latvia are: Nicaragua ($17.4M), Uzbekistan ($7.27M), Lithuania ($6.9M), Germany ($2.93M), and Ukraine ($2.85M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Latvia between 2021 and 2022 were Nicaragua ($17.4M), Uzbekistan ($3.76M), and Russia ($1.64M).

Imports In 2022, Latvia imported $201M in Vaccines, blood, antisera, toxins and cultures, becoming the 80th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 22nd most imported product in Latvia. Latvia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($62.4M), Belgium ($48.4M), Switzerland ($35M), Lithuania ($15.7M), and China ($5.78M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Latvia between 2021 and 2022 were Germany ($15.5M), Switzerland ($5.78M), and Czechia ($4.82M).